FMR LLC and Abigail P. Johnson filed Amendment No. 4 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 37,293,854 shares of Sana Biotechnology Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each reported beneficial ownership of 37,293,854 shares, representing 12.5% of Sana Biotechnology Inc. common stock.
  • Sole voting power (FMR LLC): FMR LLC reported sole voting power over 37,292,259 shares, with zero shared voting power.
  • Sole dispositive power: Both FMR LLC and Abigail P. Johnson reported sole dispositive power over 37,293,854 shares, with zero shared dispositive power.
  • Fidelity Growth Company Commingled Pool: The filing identified this entity as holding 15,131,616 shares, equal to 5.1% of total outstanding common stock, as of September 30, 2026.
  • Event date: The date of the event requiring this filing was September 30, 2026.
  • Filing classification: FMR LLC is classified as a parent holding company (HC); Abigail P. Johnson is classified as an individual (IN).

FMR LLC Discloses Increased Schedule 13G Position in Sana Biotechnology

According to the filing, FMR LLC, a Delaware-organized entity headquartered at 245 Summer Street, Boston, Massachusetts 02210, submitted Amendment No. 4 to its Schedule 13G regarding common stock of Sana Biotechnology Inc. (NASDAQ:SANA), whose principal executive offices are listed at 188 East Blaine Street, Suite 350, Seattle, WA 98102. The filing covers the CUSIP number 799566104 and reflects holdings as of September 30, 2026.

The filing reports that FMR LLC holds sole voting power over 37,292,259 shares and sole dispositive power over 37,293,854 shares. Abigail P. Johnson, filing as an individual, reported no sole or shared voting power, but reported sole dispositive power over the same 37,293,854 shares, also representing 12.5% of the class. Neither reporter disclosed any shared voting or shared dispositive power. The filing notes that "one or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of SANA BIOTECHNOLOGY INC," specifically identifying Fidelity Growth Company Commingled Pool as holding 15,131,616 shares, or 5.1% of total outstanding common stock, as of September 30, 2026.

The filing was signed by Stephanie J. Brown, acting under a Power of Attorney on behalf of both FMR LLC and Abigail P. Johnson, and dated November 4, 2026. The certification states that the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." A subsidiary identification exhibit (Exhibit 99) was attached as referenced under Item 7 of the filing.

What Was Disclosed

FMR LLC and Abigail P. Johnson filed Amendment No. 4 to their Schedule 13G disclosing combined beneficial ownership of 37,293,854 shares, or 12.5%, of Sana Biotechnology Inc. common stock as of September 30, 2026, with Fidelity Growth Company Commingled Pool identified as holding 5.1% of outstanding shares.